Market Newsdesk

NORTH PLAINS, Ore., Jan. 14, 2025 (GLOBE NEWSWIRE) — Jewett-Cameron Trading Company Ltd. (Nasdaq: JCTC), a company committed to innovative products that enrich outdoor spaces, today announced operational and financial results for the fiscal 2025 first quarter for the period ended November 30, 2024.

Recent Operational Highlights

• Achieved year-over-year growth in Q1 2025 in the Company’s fence portion of our Pet, Fencing and Other segment driven by load-in’s of new Lifetime Steel Post^® (LTP) displayers for Home Depot and Lowes. The Company doubled the new in-store LTP displayers during the first quarter bringing the total number of displayers installed to nearly 200 at the end of November 2024. Efforts to expand displayers in stores during the winter months is expected to have a positive impact in the second half of fiscal 2025 which aligns with the seasonally strong period for new fence installation commencing in the spring.
• Point-of-sale (POS) data for Adjust-A-Gate® and LTP products in key retailers highlighted strong end market year-over-year growth during Q1 2025 highlighting the success of the Company’s displayer strategy. This demonstrates the effectiveness of our in-store displays and is expected to lead to replenishment orders in the second half of fiscal 2025.
• Continued to innovate new product offerings through the launch of the new Adjust-A-Gate® Unlimited, a low profile complete gate kit. This new fence product redefines adaptability and simplicity for gate construction and is designed with flexibility and customization at its core. This innovative gate kit features a low profile, corner bracket solution that allows for fully adjustable gate designs—empowering professionals and DIYers with greater control to create gates tailored to their unique needs.
• Strategic new relationships continue to set the Company up for future success. Continental Sales & Marketing, Inc., a nationally recognized sales representative, logistics and supply chain services company, is accelerating the in-store displayer deployments and expanding distribution with key national and regional home improvement retailers,
• New multi-source, multi-country, strategic sourcing partners are creating less dependence on one specific supply source for any single product or component and are mitigating China tariffs which will help ensure continued competitiveness with our pricing.
• MyEcoWorld® compostable bin liners and pet waste bags continue to gain traction online and are being scheduled for in-store placement at multiple grocery chains in calendar year 2025. Also, the recently launched Post Consumer Recycled (PCR) pet waste bags have had initial success internationally in North America with a second order placed in Q1 2025.
• Listed for sale or lease the Company’s 11.6-acre property based in Hillsboro, Oregon that was previously a seed processing and storage facility at a current listing price of $9 million (1). The property currently has a book value of $566,022 and is unencumbered by any loans.
• Enhanced investor communications program, including the updating of the Nasdaq ticker symbol from “JCTCF” to “JCTC,” commencement of quarterly earnings calls, and participation in investor conferences has enhanced visibility of the company.

[1] This is the current asking price, and there is no guarantee the property will sell for this amount. If we are able to complete a sale, the net proceeds will be reduced by brokers’ commissions, expenses related to the sale, and taxes.

Management Discussion

“The strategic initiatives we are implementing across every key component of our operations, whether it be growth in new retailers carrying our products, enhancing strategies to improve sell-through demand for our solutions, introducing new innovative products to the market, or driving down our product costs, are aligning perfectly with the seasonal strength in demand expected in the spring when new home improvement products begin to surge,” commented Chad Summers, CEO of Jewett-Cameron. “I am extremely pleased with the progress being made as we remain on track to achieve our goals to drive growth and profitability in fiscal 2025.”

“Beyond the operational initiatives in place we have to increase our position as a leader in innovative products that enrich outdoor spaces, we also are advancing the strategic decision to exit certain non-core operations which do not align with this positioning. This focus has led to the listing for sale or lease of our 11.6-acre seed cleaning facility and property in Hillsboro, Oregon that was previously a seed processing and storage facility. The corner lot industrial property is currently listed for $9 million, but has a book value of approximately $560,000 and is unencumbered by any loans. The sale of this property has the potential to provide significant value for Jewett-Cameron going forward.”

“With a focus on driving shareholder value, we have made tremendous progress recently on four key strategic areas: growth drivers, product innovation, supply chain and operational efficiency, and asset monetization. There is more work to be done in each of these areas, however I believe we are better positioned today to deliver on the opportunity that Jewett-Cameron represents to our customers, retailer partners, and shareholders, than at any point in our recent history. I am excited about our future,” Summers concluded.

Financial Results

Revenue for Q1 2025 was $9.3 million compared to $9.8 million in Q1 2024. Q1 2025 sales of metal fencing products increased by 19% compared to Q1 2024 driven by new Lifetime Steel Post^® in-store displayers. Wood fencing product sales increased by 4% compared to the same period. Fence products represent approximately 79% of our overall sales. Demand for pet products continues to be weak, as sales in the current quarter declined by 31% compared to Q1 2024. Sales of compostable products were also down in this quarter as a customer made a large purchase in the prior year’s quarter which was not repeated in the current quarter. Sales at Greenwood for the current quarter were $0.8 million compared to $1.1 million in Q1 2024 as the prior year’s period was boosted by initial higher demand by municipalities and transit operators catching up on deferred vehicle production post-pandemic.

Gross profit margins for Q1 2025 were 18.3% compared to 19.9% in Q1 2024, and compared to 14.5% in Q4 2024. The decrease in gross profit margins from the year ago period primarily relates to higher shipping and logistic costs, particularly in sharply higher ocean shipping container rates. The costs of additional domestically produced in-store display units deployed during the current quarter also increased our costs compared to the first quarter of fiscal 2024 but we believe this to be an investment in our future growth strategy. Initiatives to improve gross margins, including new supply chain partners and enhanced pricing strategies are expected to result in margin improvements in future quarters.

Operating expenses during Q1 2025 were $2.6 million compared to $2.7 million in Q1 2024. The decrease in operating expenses is due to a reduction in professional fees from the prior year due to the settlement of a legal matter as well as initiatives taken by the Company to implement operational efficiencies and realign headcount to new business processes.

During the first quarter of fiscal 2024, the Company successfully settled a multi-year arbitration dispute with a former distributor and received a one-time cash payment of $2.45 million in October 2023. This payment offset legal fees and some of the Company’s losses in connection with the arbitration.

Loss from operations for Q1 2025 was $(0.9) million compared to $(0.8) million in Q1 2024. Net loss for Q1 2025 was $(0.7) million or $(0.19) per basic and diluted share compared to net income of $1.3 million or $0.37 per basic and diluted share in Q1 2024. The change in net loss is primarily a result of the settlement received in Q1 of last year.

As part of the Company’s initiatives to improve working capital, inventory balances decreased 23% to $13.5 million at November 30, 2024 from $17.5 at November 30, 2023. Cash balance at November 30, 2024 was $3.0 million compared to $3.6 million at November 30, 2023. The Company has no long-term debt. Total stockholders’ equity at November 30, 2024 was $24.2 million, or $6.90 per share.

Conference Call Details

Date and Time: Tuesday, January 14, 2025 at 4:30 p.m. Eastern time

Call-in Information: Interested parties can access the conference call by dialing (844) 836-8745 for United States callers or +1 (412) 317-6797.

Webcast Information: The webcast will be accessible live and archived at https://app.webinar.net/7pwdKZnKVm9, and accessible on the Investors section of the Company’s website at https://jewettcameron.com/pages/investor-relations.

Replay: A teleconference replay of the call will be available until January 21, 2025 at (877) 344-7529 for U.S. callers or +1 (412) 317-0088 for international callers and using replay access code 5685030.

About Jewett-Cameron Trading Company Ltd. (JCTC)

Jewett-Cameron Trading Company is a holding company that, through its subsidiaries, operates out of facilities located in North Plains, Oregon. Jewett-Cameron Company’s business consists of the manufacturing and distribution of patented and patent pending specialty metal and sustainable bag products, and wholesale distribution of wood products. The Company’s brands include Lucky Dog®, for pet products; Jewett Cameron Fence for brands such as Adjust-A-Gate®, Fit-Right®, Perimeter Patrol®, Euro Fence, and Lifetime Steel Post® for gates and fencing; MyEcoWorld® for sustainable bag products; and Early Start, Spring Gardner, Greenline®, and Weatherguard for greenhouses. Additional information about the Company and its products can be found on the Company’s website at www.jewettcameron.com.

Forward-looking Statements

This press release contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words like “plans”, “expects”, “aims”, “believes”, “projects”, “anticipates”, “intends”, “estimates”, “will”, “should”, “could” and similar expressions in connection with any discussion, expectation, or projection of future operating or financial performance, events or trends. Forward-looking statements are based on management’s current expectations and assumptions, which are inherently subject to uncertainties, risks and changes in circumstances that are difficult to predict, including but not limited to, the fact that our business is highly competitive, we are continually seeking ways to expand our business, we may seek additional financing or other ways to expand operations and improve margins, the uncertainties of the Company’s new product introductions, the risks of increased competition and technological change, customer concentration risk, supply chain delays, governmental and regulatory risks, as well as the other risk factors that are set forth in more detail in our Annual Report on Form 10-K and other documents filed with the SEC. Actual outcomes and results may differ materially from these expectations and assumptions due to changes in global political, economic, business, competitive, market, regulatory and other factors. We may not actually achieve the goals or plans described in our forward-looking statements, and investors should not place undue reliance on these statements. Any forward-looking statements speak only as of the date on which they are made and we undertake no obligation to publicly update or review any forward-looking information, whether as a result of new information, future developments or otherwise, except as required by law.

Investor Contact:

Robert Blum
Lytham Partners
Phone: (602) 889-9700
[email protected]

JEWETT-CAMERON TRADING COMPANY LTD. CONSOLIDATED BALANCE SHEETS (Expressed in U.S. Dollars) (Prepared by Management) (Unaudited)
	November 30, 2024			August 31, 2024
ASSETS
Current assets
Cash and cash equivalents	$	3,039,391		$	4,853,367
Accounts receivable, net of allowance of $0 (August 31, 2024 – $0)		4,183,710			3,668,815
Inventory, net of allowance of $550,000 (August 31, 2024 – $550,000)		13,491,547			13,157,243
Asset held for sale		566,022			566,022
Prepaid expenses		978,302			891,690
Prepaid income taxes		19,950			50,326
Total current assets		22,278,922			23,187,463
Property, plant and equipment, net		3,806,242			3,849,800
Intangible assets, net		112,014			112,222
Deferred tax assets		548,034			341,029
Total assets	$	26,745,212		$	27,490,514
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
Accounts payable	$	1,102,166		$	1,237,988
Accrued liabilities		1,450,619			1,401,382
Total liabilities		2,552,785			2,639,370
Stockholders’ equity
Capital stock
Authorized
21,567,564 common shares, no par value
10,000,000 preferred shares, no par value
Issued
3,504,802 common shares (August 31, 2024 – 3,504,802)		826,861			826,861
Additional paid-in capital		795,726			795,726
Retained earnings		22,569,840			23,228,557
Total stockholders’ equity		24,192,427			24,851,144
Total liabilities and stockholders’ equity	$	26,745,212		$	27,490,514

JEWETT-CAMERON TRADING COMPANY LTD. CONSOLIDATED STATEMENTS OF OPERATIONS (Expressed in U.S. Dollars) (Prepared by Management) (Unaudited)
	Three Months Ended November 30, 2024				Three Months Ended November 30, 2023
SALES	$	9,267,001			$	9,805,841
COST OF SALES		7,573,099				7,849,760
GROSS PROFIT		1,693,902				1,956,081
OPERATING EXPENSES
Selling, general and administrative expenses		809,213				948,481
Depreciation and amortization		81,066				97,903
Wages and employee benefits		1,661,768				1,698,920
		2,552,047				2,745,305
Loss from operations		(858,145	)			(789,224	)
OTHER ITEMS
Gain on sale of property, plant and equipment		800				89,655
Other income		–				2,450,000
Interest income (expense)		21,998				(6,855	)
Total other items		22,798				2,532,800
(Loss) income before income taxes		(835,347	)			1,743,576
Income tax recovery (expense)		176,630				(452,035	)
Net (loss) income	$	(658,717	)		$	1,291,541
Basic (loss) income per common share	$	(0.19	)		$	0.37
Diluted (loss) income per common share	$	(0.19	)		$	0.37
Weighted average number of common shares outstanding:
Basic		3,504,802				3,498,899
Diluted		3,504,802				3,498,899

JEWETT-CAMERON TRADING COMPANY LTD. CONSOLIDATED STATEMENTS OF CASH FLOWS (Expressed in U.S. Dollars) (Prepared by Management) (Unaudited)
	Three Months Ended November 30, 2024				Three Months Ended November 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES
Net (loss) income	$	(658,717	)		$	1,291,541
Items not involving an outlay of cash:
Depreciation and amortization		81,066				97,903
Gain on sale of property, plant and equipment		(800	)			(89,655	)
Write-down of intangible assets		–				21,790
Deferred income taxes		(207,005	)			90,813
Changes in non-cash working capital items:
(Increase) decrease in accounts receivable		(514,895	)			2,269,494
(Increase) decrease in inventory		(334,304	)			825,631
(Increase) decrease in prepaid expenses		(86,612	)			17,430
Decrease in prepaid income taxes		30,376				–
(Decrease) in accounts payable and accrued liabilities		(86,585	)			(95,032	)
Increase in income taxes payable		–				202,116
Net cash provided by (used by) operating activities		(1,777,476	)			4,632,031
CASH FLOWS FROM INVESTING ACTIVITIES
Proceeds on sale of property, plant and equipment		800				101,700
Purchase of property, plant and equipment		(37,300	)			–
Net cash provided by (used in) investing activities		(36,500	)			101,700
CASH FLOWS FROM FINANCING ACTIVITIES
(Repayment of) proceeds from bank indebtedness		–				(1,259,259	)
Net cash (used) provided by financing activities		–				(1,259,259	)
Net (decrease) increase in cash		(1,813,976	)			3,474,472
Cash, beginning of period		4,853,367				83,696
Cash, end of period	$	3,039,391			$	3,558,168

– Company views delay as imperative administrative step and symbolic win for industry against conflicted DEA –

– Company condemns agency wrongdoing and commends judge for harsh criticism of government officials –

– CEO Michael DeGiglio affirms commitment to fight for reform; calls on Trump administration to correct past failures –

ORLANDO, Fla. and VANCOUVER, British Columbia, Jan. 14, 2025 (GLOBE NEWSWIRE) — Village Farms International, Inc. (“Village Farms” or the “Company”) (NASDAQ: VFF) today issued a series of statements in response to delays in the marijuana rescheduling process resulting from its ongoing litigation against the Drug Enforcement Administration (“DEA”). The Company’s comments follow orders from the Administrative Law Judge (“ALJ”) on January 13, 2025 which granted a request for leave to file an interlocutory appeal, and referred to various DEA behavior and alleged misconduct as “unprecedented,” “astonishing,” “embarrassing,” and “demonstrate[ing] a puzzling and grotesque lack of understanding and poor judgment from high-level officials at a major federal agency.”

Michael DeGiglio, retired U.S. Navy captain, naval aviator and President, Chief Executive Officer and Founder of Village Farms commented, “We view the outcome of this past week’s proceedings as an imperative step in this administrative process, and a symbolic victory against a conflicted government agency which we believe has no current intention of recommending that cannabis be transferred to a Schedule III designation. We were given a voice in these proceedings through our selection as the only cannabis operator participant, and we intend to do everything we can to use that voice to fight for a fair and honest process with a successful outcome, and to help right the wrongdoings of decades of government corruption, bureaucracy, and the failed War on Drugs.”

Mr. DeGiglio continued, “We commend the ALJ for harsh criticism of the DEA’s defiance of this process and misconduct, which underscores our view that these proceedings are severely flawed due to the DEA’s conflicted role. A majority of Americans support legalization; millions of Americans from all walks of life increasingly rely on medical and recreational cannabis for therapeutic benefits and as substitutes for opioids and alcohol; and the scientific, medical, and civic research of cannabis conducted to date is overwhelmingly positive. The fact that the interests in health and safety of Americans continue to get steamrolled by prohibitionist efforts and competing interests is shameful and disgraceful. Our Company condemns this behavior unequivocally, and we implore the Trump administration to put a swift end to it and correct the failures of past leadership. Our constitution commences with ‘We the People’ and it’s time the federal government adhere to the will of the people and enact meaningful cannabis reform.”

About Village Farms International

Village Farms leverages decades of experience as a large-scale, Controlled Environment Agriculture-based, vertically integrated supplier for high-value, high-growth plant-based Consumer Packaged Goods. The Company has a strong foundation as the leading and longest-tenured leading fresh produce supplier to grocery and large-format retailers throughout the US and Canada and is capitalizing on new high-growth opportunities in the cannabis and CBD categories in North America, the Netherlands and selected markets internationally.

In Canada, the Company’s wholly-owned Canadian subsidiary, Pure Sunfarms, is one of the single largest cannabis operations in the world, the lowest-cost greenhouse producer and one of Canada’s best-selling brands. The Company also owns 80% of Québec-based, Rose LifeScience, a leading third-party cannabis products commercialization expert in the Province of Québec.

Internationally, Village Farms is targeting selected, nascent, legal cannabis and CBD opportunities with significant medium- and long-term potential. The Company exports medical cannabis from its EU GMP certified facility in Canada to a growing list of international markets including Germany, the United Kingdom, Israel, and Australia. The Company is expanding its international presence with additional export contracts to new countries and customers in the Asia-Pacific and European regions, as well as select strategic investments in operating assets. In Europe, wholly-owned Leli Holland has one of 10 licences to grow and distribute recreational cannabis products.

In the US, wholly-owned Balanced Health Botanicals is one of the leading CBD and hemp-derived brands and e-commerce platforms in the country. Subject to compliance with all applicable US federal and state laws and stock exchange rules, Village Farms plans to enter the US high-THC cannabis market via multiple strategies, leveraging one of the largest greenhouse operations in the country (more than 5.5 million square feet in West Texas), as well as the operational and product expertise gained through Pure Sunfarms’ cannabis success in Canada.

Village Farms Clean Energy (VFCE), through a partnership with Atlanta-based Terreva Renewables, creates clean energy from landfill gas at its Delta RNG facility. VFCE receives royalties on all revenue generated. This partnership reduces Vancouver’s greenhouse gas emissions by 475,000 metric tons of CO2 per year, equivalent to removing more than 100,000 vehicles off the road or the energy use equivalent of powering 51,300 homes for one year.

Contact Information

Sam Gibbons

Senior Vice President, Corporate Affairs

Village Farms International

Phone: (407) 936-1190 ext. 328

Email: [email protected]

– Company to Host Conference Call Today at 5:00 p.m. ET –

DURANGO, Colo., Jan. 14, 2025 (GLOBE NEWSWIRE) — Rocky Mountain Chocolate Factory Inc. (Nasdaq: RMCF) (the “Company”, “we”, or “RMCF”), an international franchisor and producer of premium chocolates and other confectionery products including gourmet caramel apples, is reporting financial and operating results for its fiscal third quarter ended November 30, 2024.

“We continue to make progress in strengthening RMCF’s foundation for long-term success,” said Jeff Geygan, Interim CEO of RMCF. “We have been focused on improving the Company’s liquidity, rebuilding a strong executive team, expanding our franchise network, and returning RMCF to sustainable growth and profitability. While there is more to do, I am pleased to report that we are executing across multiple fronts.

“During the quarter, we secured a three-year $6 million credit agreement to replace our prior facility, invest further in equipment and machinery, and fund growth initiatives. We also made key hires in franchise support and marketing while adding two prominent executives to our Board. Further, in November we announced plans for two new stores and a kiosk location across three U.S. markets.

“After quarter-end, we had a strong holiday season where we effectively fulfilled all franchisee and specialty market demand. And in January, we launched our new ERP system, which is an important investment to enhance operational visibility and decision making across the organization. We believe this new system will drive efficiencies over time, particularly in managing supply and labor costs that affected margins during our fiscal third quarter.”

Geygan added, “Looking ahead to calendar 2025, we are taking decisive action to address inefficiencies in our business and position RMCF for growth and profitability. With a stronger balance sheet, a growing franchise pipeline, and investments in our operating infrastructure, we are laying the groundwork to execute our strategic initiatives with discipline and focus. We believe these efforts will position RMCF to deliver long-term value for our franchisees, customers and shareholders.”

Fiscal Third Quarter 2025 Financial Results vs. Year-Ago Quarter

• Total revenue for the third quarter of 2025 increased to $7.9 million compared to $7.7 million in the year-ago quarter.
• Total product and retail gross profit was essentially flat at $0.7 million for the third quarter of 2025 compared to the year-ago quarter. Gross margin was 10.0% for the third quarter of 2025 compared to 10.2% for the year-ago quarter. The decrease in gross margin was primarily driven by higher supply and labor costs.
• Total Costs and Expenses increased to $8.6 million compared to $8.5 million in the year-ago quarter.
• Net loss for the third quarter 2025 was $0.8 million or $(0.11) per share, compared to net loss of $0.8 million or $(0.12) per share in the year-ago quarter.
• Adjusted EBITDA (a non-GAAP measure defined below) improved to $41,000 compared to $(0.3) million in the year-ago period.

Conference Call Information

The Company will conduct a conference call today at 5:00 p.m. Eastern time to discuss its financial results. A question-and-answer session will follow management’s opening remarks. The conference call details are as follows:

Date: Tuesday, January 14, 2025
Time: 5:00 p.m. Eastern time
Dial-in registration link: here
Live webcast registration link: here

Please dial into the conference call 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact the Company’s investor relations team at [email protected].

The conference call will also be broadcast live and available for replay in the investor relations section of the Company’s website at https://ir.rmcf.com/.

About Rocky Mountain Chocolate Factory, Inc.

R
ocky Mountain Chocolate Factory, Inc.
is an international franchiser of premium chocolate and confection stores, and a producer of an extensive line of premium chocolates and other confectionery products, including gourmet caramel apples. Headquartered in Durango, Colorado, Rocky Mountain Chocolate Factory is ranked among Entrepreneur’s Franchise 500^® and Franchise Times’ Franchise 400^® for 2024. The Company and its franchisees and licensees operate nearly 260 Rocky Mountain Chocolate stores across the United States, with several international locations. The Company’s common stock is listed on the Nasdaq Global Market under the symbol “RMCF.”

Non-GAAP Financial Measures

To supplement the Company’s consolidated financial statements, which are prepared and presented in accordance with GAAP, the Company provides investors with certain non-GAAP financial measures, such as Adjusted EBITDA. The presentation of these non-GAAP financial measures is not intended to be considered in isolation or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP.

This non-GAAP financial measure may have limitations as an analytical tool, and this measure should not be considered in isolation or as a substitute for analysis of results as reported under GAAP. Management uses Adjusted EBITDA because it believes that Adjusted EBITDA provides additional analytical information on the nature of ongoing operations excluding expenses not expected to recur in future periods, non-cash charges and variations in the effective tax rate among periods. Management believes that Adjusted EBITDA is useful to investors because it provides a measure of operating performance and its ability to generate cash that is unaffected by non-cash accounting measures and non-recurring expenses. However, due to these limitations, management uses Adjusted EBITDA as a measure of performance only in conjunction with GAAP measures of performance such as income/loss from continuing operations and net income.

The Company is not providing a reconciliation for future expectations of Adjusted EBITDA due to the volatility of certain required inputs that are not available without unreasonable efforts.

Forward-Looking Statements

This press release includes statements of our expectations, intentions, plans and beliefs that constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to come within the safe harbor protection provided by those sections. These forward-looking statements involve various risks and uncertainties. The statements, other than statements of historical fact, included in this press release are forward-looking statements. Many of the forward-looking statements contained in this document may be identified by the use of forward-looking words such as “will,” “intend,” “believe,” “expect,” “anticipate,” “should,” “plan,” “estimate,” “potential,” or similar expressions. However, the absence of these words or similar expressions does not mean that a statement is not forward-looking. All statements that address operating performance, events or developments that we expect or anticipate will occur in the future – including statements expressing general views about future operational performance, financial results and execution of the Company’s strategic plan – are forward-looking statements. Management of the Company believes that these forward-looking statements are reasonable as and when made. However, caution should be taken not to place undue reliance on any such forward-looking statements because such statements speak only as of the date of this press release. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. In addition, forward-looking statements are subject to certain risks and uncertainties that could cause our Company’s actual results to differ materially from historical experience and our present expectations or projections. These risks and uncertainties include, but are not limited to: inflationary impacts, changes in the confectionery business environment, seasonality, consumer interest in our products, receptiveness of our products internationally, consumer and retail trends, costs and availability of raw materials, competition, the success of our co-branding strategy, the success of international expansion efforts and the effect of government regulations. For a detailed discussion of the risks and uncertainties that may cause our actual results to differ from the forward-looking statements contained herein, please see the section entitled “Risk Factors” contained in our most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q, each filed with the Securities and Exchange Commission.

Investor Contact

Sean Mansouri, CFA
Elevate IR
720-330-2829
[email protected]

Rocky Mountain Chocolate Factory, Inc. and Subsidiaries Condensed Consolidated Balance Sheets (In thousands, except share and per share amounts) (Unaudited)
	November 30, 2024 (unaudited)				February 29, 2024
Assets
Current Assets
Cash and cash equivalents	$	1,089			$	2,082
Accounts receivable, less allowance for credit losses of $383 and $332, respectively		4,100				2,184
Notes receivable, current portion, less current portion of the allowance for credit losses of $2 and $30, respectively		40				489
Refundable income taxes		63				46
Inventories		5,722				4,358
Other		256				443
Total current assets		11,270				9,602
Property and Equipment, Net		8,071				7,758
Other Assets
Notes receivable, less current portion and allowance for credit losses of $28 and $0, respectively		51				695
Goodwill		576				576
Intangible assets, net		215				238
Lease right of use asset		1,352				1,694
Other		99				14
Total other assets		2,293				3,217
Total Assets	$	21,634			$	20,577
Liabilities and Stockholders’ Equity
Current Liabilities
Accounts payable	$	2,083			$	3,411
Line of credit		–				1,250
Accrued salaries and wages		811				1,833
Gift card liabilities		628				624
Other accrued expenses		183				301
Contract liabilities		140				150
Lease liability		494				503
Total current liabilities		4,339				8,072
Note payable		6,000				–
Lease Liability, Less Current Portion		861				1,191
Contract Liabilities, Less Current Portion		600				678
Total Liabilities		11,800				9,941
Commitments and Contingencies
Stockholders’ Equity
Preferred stock, $.001 par value per share; 250,000 authorized; 0 shares issued and outstanding		–				–
Common stock, $.001 par value, 46,000,000 shares authorized, 7,667,264 shares and 6,306,027 shares issued and outstanding, respectively		8				6
Additional paid-in capital		12,319				9,896
Retained earnings (accumulated deficit)		(2,493	)			734
Total stockholders’ equity		9,834				10,636
Total Liabilities and Stockholders’ Equity	$	21,634			$	20,577

Rocky Mountain Chocolate Factory, Inc. and Subsidiaries Condensed Consolidated Statements of Operations (In thousands, except per share amounts) (Unaudited)
	Three Months Ended								Nine Months Ended
	November 30,								November 30,
	2024				2023				2024				2023
Revenues
Sales	$	6,719			$	6,421			$	16,916			$	16,453
Franchise and royalty fees		1,174				1,276				3,764				4,238
Total Revenue		7,893				7,697				20,680				20,691
Costs and Expenses
Cost of sales		6,044				5,769				15,980				15,159
Franchise costs		616				577				2,109				1,870
Sales and marketing		272				572				840				1,487
General and administrative		1,427				1,333				4,288				4,952
Retail operating		171				186				564				451
Depreciation and amortization, exclusive of depreciation and amortization expense of $211, $188, $598 and $541, respectively, included in cost of sales		63				36				143				99
Total costs and expenses		8,593				8,473				23,924				24,018
Loss from Operations		(700	)			(776	)			(3,244	)			(3,327	)
Other Income (Expense)
Interest expense		(160	)			(11	)			(258	)			(24	)
Interest income		7				30				21				68
Gain on disposal of assets		6				–				254				–
Other income (expense), net		(147	)			19				17				44
Loss Before Income Taxes		(847	)			(757	)			(3,227	)			(3,283	)
Income Tax Provision (Benefit)		–			–					–			–
Loss from Continuing Operations		(847	)			(757	)			(3,227	)			(3,283	)
Discontinued Operations
Earnings from discontinued operations, net of tax	–				–				–				69
Gain on disposal of discontinued operations, net of tax	–				–				–					635
Earnings from discontinued operations, net of tax	–				–				–				704
Net Loss	$	(847	)		$	(757	)		$	(3,227	)		$	(2,579	)
Basic Loss per Common Share
Loss from continuing operations	$	(0.11	)		$	(0.12	)		$	(0.47	)		$	(0.51	)
Earnings from discontinued operations		–			–					–				0.11
Net loss	$	(0.11	)		$	(0.12	)		$	(0.47	)		$	(0.40	)
Diluted Loss per Common Share
Loss from continuing operations	$	(0.11	)		$	(0.12	)		$	(0.47	)		$	(0.51	)
Earnings from discontinued operations		–			–					–				0.11
Net loss	$	(0.11	)		$	(0.12	)		$	(0.47	)		$	(0.40	)
Weighted Average Common Shares Outstanding – Basic		7,643,690				6,302,159				6,883,263				6,290,575
Dilutive Effect of Employee Stock Awards		–			–					–			–
Weighted Average Common Shares Outstanding – Diluted		7,643,690				6,302,159				6,883,263				6,290,575

Rocky Mountain Chocolate Factory, Inc. and Subsidiaries GAAP Reconciliation of Adjusted EBITDA (In thousands, except per share amounts) (Unaudited)
	Three Months Ended November 30,
		2024				2023
GAAP Income (Loss) from Operations	$	(700	)		$	(775	)
Depreciation and Amortization		274				223
Stock-based Compensation		237				166
Costs Associated with Non-recurring Expenses		230				91
Adjusted EBITDA	$	41			$	(295	)

BOSTON, Jan. 14, 2025 (GLOBE NEWSWIRE) — Rapid7, Inc. (NASDAQ: RPD), a leader in extended risk and threat detection, today announced that the company will release its fourth quarter and full year 2024 financial results on Wednesday, February 12, 2025, after the financial markets close.

The company will host a conference call that same day to discuss its results and business outlook at 4:30 p.m. Eastern Time. The call will be accessible by telephone at +1 888-330-2384 (toll-free) or +1 240-789-2701 with the event code 8484206.

The conference call will also be available live via webcast on the company’s website at https://investors.rapid7.com. A webcast replay of the call will be available at https://investors.rapid7.com.

About Rapid7

Rapid7 (Nasdaq: RPD) is on a mission to create a safer digital world by making cybersecurity simpler and more accessible. We empower security professionals to manage a modern attack surface through our best-in-class technology, leading-edge research, and broad, strategic expertise. Rapid7’s comprehensive security solutions help more than 11,000 global customers unite cloud risk management and threat detection to reduce attack surfaces and eliminate threats with speed and precision. For more information, visit our website, check out our blog, or follow us on LinkedIn or Twitter.

Rapid7
Investor Contact:

Elizabeth Chwalk
Senior Director, Investor Relations
[email protected]
(617) 865-4277

Rapid7
Press
C
ontact:

Alice Randall
Director, Global Corporate Communications
[email protected]
(857) 216-7804

Full-Year 2024 Total Revenue Growth of 20% and Adjusted EBITDA Growth of Approximately 55%

MACI Full-Year 2024 Revenue Growth of 20%, with Fourth Quarter Revenue of $68.2 to $68.7 Million

Highest Quarterly MACI Implants, Surgeons, and Biopsies Since Launch and Strong Early MACI Arthro Launch Indicators

Record Fourth Quarter Gross Margin of Approximately 77% and Adjusted EBITDA Margin of 39%

2025 Total Revenue Guidance of 20% to 23% Growth

Mid-Term Profitability Targets Increased to Gross Margin in the High-70% Range and Adjusted EBITDA Margin in the High-30% Range

CAMBRIDGE, Mass., Jan. 14, 2025 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced preliminary, unaudited financial results for the fourth quarter and year ended December 31, 2024, full-year 2025 financial guidance and updated mid-term profitability targets.

Preliminary, Unaudited Full-Year 2024 Financial Results

• Total net revenue expected to be approximately $237 to $237.5 million, representing 20% growth
• MACI^® net revenue expected to be approximately $197.2 to $197.7 million, representing 20% growth
• Burn Care net revenue expected to be approximately $40 million, representing 22% growth, consisting of approximately $36.6 million of Epicel^® revenue and $3.3 million of NexoBrid^® revenue
• Gross margin expected to be approximately 72.5%
• Achieved Full-Year GAAP Net Income profitability
• Non-GAAP adjusted EBITDA margin expected to be approximately 22%
• As of December 31, 2024, the Company had approximately $167 million in cash, restricted cash and investments, and no debt, an increase of approximately $16 million for the quarter

Preliminary, Unaudited Fourth Quarter Financial Results

• Total net revenue expected to be approximately $75.2 million to $75.7 million
• MACI net revenue expected to be approximately $68.2 to $68.7 million, representing 20% to 21% growth versus the prior year and approximately 53% growth versus the prior quarter
• Burn Care net revenue expected to be approximately $7 million, consisting of approximately $6 million of Epicel revenue and $1 million of NexoBrid revenue
• Gross margin expected to be approximately 77%
• GAAP Net Income expected to be approximately $17.5 to $18.5 million
• Non-GAAP adjusted EBITDA margin expected to be approximately 39%

Key Business Highlights and Updates

• Highest number of MACI implants, implanting surgeons, surgeons taking biopsies and MACI biopsies in any quarter since launch in the fourth quarter
• More than 150 MACI Arthro trained surgeons through year-end
• NexoBrid hospital orders in the fourth quarter increased approximately 40% versus the prior quarter
• Completed construction of new corporate headquarters and manufacturing facility and remain on track to initiate commercial manufacturing in the new facility in 2026

2025 Financial Guidance

• Total net revenue growth for 2025 expected to be 20% to 23%
• Gross margin expected to be 73% to 74%
• Adjusted EBITDA margin expected to be 25% to 26%

Mid-Term Profitability Targets

• Gross margin is expected to increase to the high-70% range by 2029
• Adjusted EBITDA margin expected to increase to the high-30% range by 2029

“The Company executed extremely well in 2024, delivering high revenue growth across both franchises and very strong margin expansion and profitability,” said Nick Colangelo, President and CEO of Vericel. “We are entering 2025 with a great deal of momentum and expect another year of high revenue growth, increasing utilization of MACI Arthro and significant growth in profitability and cash generation as we continue to progress toward our mid-term financial targets.”

Vericel is scheduled to present at the 43^rd Annual J.P. Morgan Healthcare Conference at 10:30 a.m. ET (7:30 a.m. PT) on Wednesday, January 15, 2025. A webcast of the presentation will be available on the Investor Relations section of the Vericel Corporation website at: http://investors.vcel.com.

About Vericel Corporation

Vericel is a leading provider of advanced therapies for the sports medicine and severe burn care markets. The Company combines innovations in biology with medical technologies, resulting in a highly differentiated portfolio of innovative cell therapies and specialty biologics that repair injuries and restore lives. Vericel markets three products in the United States. MACI (autologous cultured chondrocytes on porcine collagen membrane) is an autologous cellularized scaffold product indicated for the repair of symptomatic, single or multiple full-thickness cartilage defects of the knee with or without bone involvement in adults. Epicel (cultured epidermal autografts) is a permanent skin replacement for the treatment of patients with deep dermal or full thickness burns greater than or equal to 30% of total body surface area. Vericel also holds an exclusive license for North American rights to NexoBrid (anacaulase-bcdb), a biological orphan product containing proteolytic enzymes, which is indicated for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness burns. For more information, please visit www.vcel.com.

Epicel^® and MACI^® are registered trademarks of Vericel Corporation. NexoBrid^® is a registered trademark of MediWound Ltd. and is used under license to Vericel Corporation. © 2025 Vericel Corporation. All rights reserved.

Preliminary and Unaudited Nature of Reported Results

Our revenue expectations for the fourth quarter and full-year ended 2024, as well as our estimates concerning gross margin, net income, adjusted EBITDA, cash, restricted cash and investments are preliminary, unaudited and are subject to change based on the completion of ongoing internal control, review, and audit procedures. As a result, these amounts may differ materially from the amounts that will be reflected in the Company’s consolidated financial statements for the year ended December 31, 2024. Accordingly, you should not place undue reliance on this preliminary estimate.

GAAP v. Non-GAAP Measures

Vericel’s reported earnings are prepared in accordance with generally accepted accounting principles in the United States, or GAAP, and represent earnings as reported to the Securities and Exchange Commission. Vericel has provided in this release certain financial information that has not been prepared in accordance with GAAP. Vericel’s management believes that the non-GAAP adjusted EBITDA described in this release, which includes adjustments for specific items that are generally not indicative of our core operations, provides additional information that is useful to investors in understanding Vericel’s underlying performance, business and performance trends, and helps facilitate period-to-period comparisons and comparisons of its financial measures with other companies in Vericel’s industry. However, the non-GAAP financial measures that Vericel uses may differ from measures that other companies may use. Non-GAAP financial measures are not required to be uniformly applied, are not audited and should not be considered in isolation or as substitutes for results prepared in accordance with GAAP.

Forward-Looking Statements

Vericel cautions you that all statements other than statements of historical fact included in this press release that address activities, events or developments that we expect, believe or anticipate will or may occur in the future are forward-looking statements. Although we believe that we have a reasonable basis for the forward-looking statements contained herein, they are based on current expectations about future events affecting us and are subject to risks, assumptions, uncertainties and factors relating to our operations and business environment, all of which are difficult to predict and many of which are beyond our control. Our actual results may differ materially from those expressed or implied by the forward-looking statements in this press release. These statements are often, but are not always, made through the use of words or phrases such as “anticipates,” “intends,” “estimates,” “plans,” “expects,” “continues,” “believe,” “guidance,” “outlook,” “target,” “future,” “potential,” “goals” and similar words or phrases, or future or conditional verbs such as “will,” “would,” “should,” “could,” “may,” or similar expressions.

Among the factors that could cause actual results to differ materially from those set forth in the forward-looking statements include, but are not limited to, the inherent uncertainties associated with our expectations concerning expected revenue results for the fourth quarter and full-year ended 2024, gross margin, net income, adjusted EBITDA, and estimates of our cash, restricted cash and investments as of December 31, 2024. Vericel’s revenue expectations for the fourth quarter and full-year ended 2024, as well as its estimates concerning gross margin, net income, adjusted EBITDA, and cash, restricted cash and investments are preliminary, unaudited and are subject to change during ongoing internal control, review and audit procedures. Additional factors that could cause actual results to differ materially from those set forth in the forward-looking statements include, but are not limited to, uncertainties associated with our expectations regarding future revenue, growth in revenue, market penetration for MACI, MACI Arthro, Epicel, and NexoBrid, growth in profit, gross margins and operating margins, the ability to continue to scale our manufacturing operations to meet the demand for our cell therapy products, including the timely qualification of a new manufacturing facility in Burlington, Massachusetts, the ability to sustain profitability, contributions to adjusted EBITDA, the expected target surgeon audience, potential fluctuations in sales and volumes and our results of operations over the course of the year, timing and conduct of clinical trial and product development activities, timing and likelihood of the FDA’s potential approval of the use of MACI to treat cartilage defects in the ankle, the estimate of the commercial growth potential of our products and product candidates, competitive developments, changes in third-party coverage and reimbursement, surgeon adoption of MACI Arthro, physician and burn center adoption of NexoBrid, labor strikes, changes in surgeon and hospital treatment prioritizations caused by the temporary shortage of essential medical supplies, supply chain disruptions or other events or factors that might affect our ability to manufacture MACI or Epicel or affect MediWound’s ability to manufacture and supply sufficient quantities of NexoBrid to meet customer demand, including but not limited to, damage or disruption caused by natural disasters and the ongoing military conflicts in the Middle East region involving Israel, negative impacts on the global economy and capital markets resulting from the conflict in Ukraine and the Middle East conflicts, changes in trade policies and regulations, including the potential for increases or changes in duties, current and potentially new tariffs or quotas, lingering effects of adverse developments affecting financial institutions, companies in the financial services industry or the financial services industry generally, possible changes in governmental monetary and fiscal policies, including, but not limited to, Federal Reserve policies in connection with continued inflationary pressures and the impact of the recent elections in the United States, global geopolitical tensions and potential future impacts on our business or the economy generally stemming from a public health emergency.

These and other significant factors are discussed in greater detail in Vericel’s Annual Report on Form 10-K for the year ended December 31, 2023, filed with the Securities and Exchange Commission (SEC) on February 29, 2024, Vericel’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, filed with the SEC on November 7, 2024, and in other filings with the SEC. These forward-looking statements reflect our views as of the date hereof and Vericel does not assume and specifically disclaims any obligation to update any of these forward-looking statements to reflect a change in its views or events or circumstances that occur after the date of this press release except as required by law.

Investor Contact:
Eric Burns
[email protected]
+1 (734) 418-4411

Zhongshan, China, Jan. 14, 2025 (GLOBE NEWSWIRE) — Wing Yip Food Holdings Group Limited (the “Company” or “Wing Yip”) (Nasdaq: WYHG), a meat product processing company through its operating subsidiaries in mainland China, today announced that the underwriters of its initial public offering (the “Offering”) have exercised their over-allotment option in full to purchase an additional 307,500 American Depositary Shares (“ADSs”) at the public offering price of US$4.00 per ADS, resulting in additional gross proceeds of $1,230,000. Each ADS represents one ordinary share of the Company. After giving effect to the full exercise of the over-allotment option, the total number of ADSs sold by the Company in the public offering increased to 2,357,500 ADSs and the gross proceeds increased to approximately US$9.43 million, before deducting underwriter discounts and other related expenses. The option closing date was January 14, 2025. The ADSs commenced trading on the Nasdaq Capital Market on November 26, 2024 under the ticker symbol “WYHG.”

Dawson James Securities, Inc. and D. Boral Capital LLC acted as the underwriters (collectively, the “Underwriters”) for the Offering. Hunter Taubman Fischer & Li LLC acted as U.S. securities counsel to the Company, and Nelson Mullins Riley & Scarborough LLP acted as U.S. counsel to the Underwriters in connection with the Offering.

The Company intends to use the proceeds from the Offering for (i) upgrading existing production lines and establishing new production lines; (ii) marketing and promotion of the Company’s products; (iii) new product research and development; and (iv) working capital and general corporate matters.

A registration statement on Form F-1 (File Number: 333-277694), as amended, relating to the Offering (the “Registration Statement”) was filed with the U.S. Securities and Exchange Commission (the “SEC”) and was declared effective by the SEC on November 6, 2024. The Offering was made only by means of a prospectus, forming a part of the Registration Statement. Copies of the prospectus relating to the Offering may be obtained from Dawson James Securities, Inc., at 101 North Federal Highway, Suite 600, Boca Raton, FL 33432, or by telephone at (561) 391-5555, or by email at [email protected]; or by contacting D. Boral Capital LLC, at Syndicate Department, 590 Madison Avenue, 39th Floor, New York, NY 10022, or by email at [email protected], or by telephone at (212) 970-5150​. In addition, copies of the prospectus relating to the Offering may be obtained via the SEC’s website at www.sec.gov.

This press release does not constitute an offer to sell, or the solicitation of an offer to buy, any of the Company’s securities, nor shall there be any offer, solicitation or sale of any of the Company’s securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.

About Wing Yip Food Holdings Group Limited

Wing Yip, is a meat product processing company in mainland China. The Company, through its operating subsidiaries, sells and markets products under its flagship brand, “Wing Yip,” which can trace its history back to 1915, and has also developed the snack product brands, “Jiangwang” and “Kuangke.” The Company’s products are sold through its self-operated stores, distributors, and e-commerce platforms in over 18 provinces across mainland China. The Company offers cured meat products, snack products, and frozen meat products, processing them through its own dedicated production lines. The Company focuses on product development and is committed to improving product quality and expanding product offerings to cater to evolving consumer preferences. The Company’s ordinary shares have been listed on the Korea Securities Dealers Automated Quotations of the Korea Exchange since 2018.

For more information, please visit the Company’s website: http://ir.wingyip-food.com/. Information on the Company’s website does not constitute a part of and is not incorporated by reference into this press release.

Forward-Looking Statements

Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,” “potential,” “continue” or other similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations that arise after the date hereof, except as may be required by law. These statements are subject to uncertainties and risks, including, but not limited to, the uncertainties related to market conditions, and other factors discussed in the “Risk Factors” section of the Registration Statement filed with the SEC. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s Registration Statement and other filings with the SEC. Additional factors are discussed in the Company’s filings with the SEC, which are available for review at
www.sec.gov
.

For more information, please contact:

Wing Yip Food Holdings Group Limited

Investor Relations Department
Email: [email protected]

Ascent Investor Relations LLC

Tina Xiao
Phone: +1-646-932-7242
Email: [email protected]

Sheng-Kai (Scott) Hsu Appointed as Chief Financial Officer of Armlogi, Transitioning from Board Secretary

Zhiliang (Ian) Zhou to Remain with Armlogi in an Advisory Role

WALNUT, CA, Jan. 14, 2025 (GLOBE NEWSWIRE) — Armlogi Holding Corp. (“Armlogi” or the “Company”) (Nasdaq: BTOC), a U.S.-based warehousing and logistics service provider that offers a comprehensive package of supply-chain solutions related to warehouse management and order fulfillment, today announced a transition in its executive leadership. Sheng-Kai (Scott) Hsu has been appointed as the Chief Financial Officer of Armlogi, effective January 13, 2025, succeeding Zhiliang (Ian) Zhou, who will remain with the Company in an advisory capacity while pursuing other career opportunities.

Scott Hsu, who joined Armlogi as the accounting lead in July 2024, brings financial management expertise from the manufacturing and wholesale sectors. Previously, Mr. Hsu served as North America Controller at PARPRO Technologies Inc., managing finance teams across the U.S. and Mexico and ensuring compliance with U.S. GAAP and international standards. His previous experience also includes roles at Absen Inc. and BENQ Latin America Corp., where he improved financial processes and systems. Mr. Hsu is a Certified Public Accountant (CPA) and Certified Management Accountant (CMA), holding a Master of Science in Finance from Johns Hopkins University.

Ian Zhou has served as Armlogi’s Chief Financial Officer since August 2023. Mr. Zhou has over 10 years of experience in the capital markets and financial industry, with a track record of success in leading and executing complex financial transactions. He has made significant contributions to Armlogi, leading the Company through its successful initial public offering in 2024 and in its recent financings, including $21 million in convertible promissory notes and a $50 million standby equity purchase agreement. His strategic insight and financial acumen have been pivotal in positioning Armlogi for sustained growth and profitability.

Aidy Chou, Chairman and Chief Executive Officer of Armlogi, commented, “We are immensely grateful to Ian for his financial leadership and strategic vision, which have strengthened Armlogi’s financial foundation and contributed significantly to our market achievements. As we welcome Scott into his new role, we are confident that his extensive experience and strategic approach to financial management will continue to drive Armlogi’s success in the logistics industry.”

Ian Zhou commented, “I am grateful for the opportunity to have led Armlogi’s financial operations and to have guided our team through significant milestones, including our initial public offering. I am excited to continue supporting the Company in a new capacity and am confident in its future success under Scott’s financial stewardship.”

Scott Hsu commented on his new role, saying, “I am thrilled to step into the role of CFO at such a pivotal time for Armlogi. I look forward to building on the strong foundation laid by Ian and the team, driving forward our financial strategies to support Armlogi’s growth and operational excellence.”

About Armlogi Holding Corp.

Armlogi Holding Corp., based in Walnut, CA, is a fast-growing U.S.-based warehousing and logistics service provider that offers a comprehensive package of supply-chain solutions relating to warehouse management and order fulfillment. The Company caters to cross-border e-commerce merchants looking to establish overseas warehouses in the U.S. market. With eleven warehouses covering over three and a half million square feet, the Company offers comprehensive one-stop warehousing and logistics services. The Company’s warehouses are equipped with facilities and technology for handling and storing large and bulky items. For more information, please visit www.armlogi.com.         

Safe Harbor Statement

This press release contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us.

Company Contact:

[email protected]

Investor Relations Contact:

Matthew Abenante, IRC
President
Strategic Investor Relations, LLC
Tel: 347-947-2093
Email: [email protected]